The Directors of Futura Medical plc recognise the importance of sound corporate governance and have chosen to apply the Quoted Companies Alliance Corporate Governance Code (the "QCA Code").

The QCA Code takes key elements of good governance and applies them in a manner that is workable for the different needs of growing companies and was developed by the Quoted Companies Alliance as an alternative corporate governance code applicable to AIM companies.

The QCA Code corporate governance arrangements that the Board has adopted are designed to ensure that the group delivers long term value to its shareholders and that shareholders have the opportunity to express their views and expectations for the group in a manner that encourages open dialogue with the Futura Medical plc Board.

The Board has the overall responsibility to set strategy for the Group, and monitor the performance of the operating subsidiaries. The Subsidiary Boards have the responsibility to oversee, govern and direct the operations of the subsidiary entities in line with relevant rules and regulations and overall Group strategy.

The respective Boards have established various committees, each of which has written terms of reference. The principal committees are the Audit, Remuneration, Risk and Oversight and Nomination Committees. In September 2018, the Board approved the application of the QCA Corporate Governance Code (2018 edition) (the Code). The Board views this as an appropriate corporate governance framework for Futura Medical plc, and consideration has been given to each of the ten principles set out in the code.

The Directors of Futura Medical plc recognise the importance of sound corporate governance and have chosen to apply the Quoted Companies Alliance Corporate Governance Code (the "QCA Code").

Click on the plus icons to view the application of each principle.